HbA1c and BMI after lockdown for COVID-19 in children and adolescents with type 1 diabetes mellitus.

Despite the potential deleterious effect of COVID-19 lockdown on individuals with type 1 diabetes mellitus (T1DM), a stable or even improved glycaemic control has been reported in paediatric subjects treated with continuous subcutaneous insulin infusion (CSII) using continuous or flash glucose monitoring (CGM/FGM). (1-2) To date, only two Indian studies evaluated the changes in HbA1c in paediatric individuals treated with multi-daily injections (MDI) with conflicting results (3-4). Additionally, although there are some weight gain reports in children during the lockdown, only one study focused on individuals with T1DM (3).